Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.

Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. · 2021

Read Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. by Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8691037.txt.

Description

Dai and co-authors review how epigenetic drugs can boost anti-tumor immunity and improve cancer immunotherapy. Chemical marks on DNA and its packaging shape gene use. These marks guide immune cell growth and action. They also set how visible cancer cells are to the immune system.

Key immune genes and checkpoint proteins are under epigenetic control. Drugs that shift these marks can reprogram cells in the tumor. They may curb suppressor cells and wake killer T cells. They can also raise tumor antigens and display machinery in cancer cells. The review sums up this fast-moving field. Its aim is stronger and wider immune attack on tumors.

Catalog record

CREATORDai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE142 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8691037

Browse the full library · About the Tower of Babel